Back to results
US 9,592,292 B1Granted
Silicon nanoparticle for photodynamic cancer treatment utilizing quantum dot optical properties
OwnerJames Beckman, Anatoli Ischenkoinventors
Life of this patent
Estimating the term…
Abstract
Quantum active sized silicon nanoparticles with a silicon core covered by a thin 0.5-1.5 nm oxide/nitride shell are described for light exposure in the 300-600 nm range for transforming atmospheric oxygen to singlet oxygen for causing cell apoptosis as a type of photodynamic cancer therapy. A method of use of the nanoparticle in a non-hydrophobic cream is also taught along with a blocking scheme for controlled reaction of the nanoparticle.
Claims7
A method for skin cancer treatment comprising:
- a) providing a medium comprising photo-sensibilizing nanoparticles, wherein the nanoparticles comprise
- a silicon core;
- and
- an individually discrete reactant outer shell having a thickness less than 1.5 nanometers, the silicon core and an individually discrete reactant outer shell, forming a colloid-free and individually discrete nanoparticle;
- the reactant outer shell formed from at least one shell reactant selected from the reactant group consisting of oxygen and nitrogen, and
- the combined silicon core and reactant outer shell having a cross section distance of greater than 2 and less than 9 nanometers;
- b) placing the medium comprising photo-sensibilizing nanoparticles provided in step (a) on the surface of skin cancer cells in a free oxygen environment;
- c) irradiating the medium covering the cancer cells with a laser or light beam in the visible spectrum of 320-650 nanometer wavelength;
- wherein exposure of the nanoparticle to the laser or light beam causes formation of singlet oxygen from the oxygen molecules adjacent the exterior surface of the nanoparticle, which results in the death of cancer cells.
6 more elements
Dependencies are inferred from the claim text.